Cambridge Enterprise comes out on top for money returned on investments with impressive numbers across the board.

Imperial Innovations reinvests in Imperial College London spinout Inflowmatix in a $4.3m series A round that also gained investment from Parkwalk Advisors.

Drug developer Ergomed acquires Leicester spinout Haemostatix, which is developing a blood clotting peptide sequence, for $11.5m upfront and a potential future payment of $29m.

Two Portuguese corporates, Caixa and Sonae, have joined forces to support the retail analytics startup

Biovotion has secured a first close for its series A round, backed by Swiss Re and STMicroelectronics.

Commercialisation bootcamp supports UCD researchers as they learn how to bring their ideas, such as a formaldehyde replacement and a rapid, low-cost multiple sclerosis test, to market.

Delft University of Technology's Robovalley centre co-creates a $112m robotics fund to support companies working to commercialise robotic technology.

Germany-based drugs group Merck Ventures now manages $340m.